跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AB-14
首页
药物
AB-14
AB-14
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ADENOVIRUS CONSTRUCTS AND METHODS OF USE
申请人: UNIV MINNESOTA
优先权: 2023
US
Alkyl benzoate mixtures
申请人: COGNIS IP MAN GMBH
优先权: 2006
EP
Anti-idiotypic antibodies neutralising the inhibiting activity of an inhibiting antibody directed against domain C1 of factor VIII
申请人: LFB BIOTECHNOLOGIES
优先权: 2007
EP
MACROCYCLIC PEPTIDE COMPOUND HAVING CELL MEMBRANE PERMEABILITY AND METABOLIC STABILITY, AND LIBRARY CONTAINING SAME
申请人: CHUGAI PHARMACEUTICAL CO LTD
优先权: 2023
CN
EP
WO
3 件公开
Mog1 gene knockout zebrafish model and application
申请人: ZHOU JUAN
优先权: 2021
CN
Medicinal salt of fused ring compound, crystal form and application thereof
申请人: SUZHOU SHENGDIYA BIOLOGICAL MEDICINE CO LTD
优先权: 2024
CN
2 件公开
Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
申请人: IOVANCE BIOTHERAPEUTICS INC
优先权: 2017
US
4 件公开
Polymorphic substance of aza-tetraepoxy aza inhibitor of KRAS-G12D and synthetic method
申请人: GENENTECH INC
优先权: 2023
CN
药物
反馈